Pharmacological potential of phytoestrogens in the treatment of prostate cancer [Das pharmakologische potential von phytoöstrogenen in der therapie des prostatakarzinoms]

被引:0
|
作者
Thelen P. [1 ]
Seseke F. [1 ,3 ]
Ringert R.-H. [1 ]
Wuttke W. [2 ]
Seidlová-Wuttke D. [2 ]
机构
[1] Klinik für Urologie, Georg-August Universität, Göttingen
[2] Klinische und Experimentelle Endokrinologie, Georg-August Universität, Göttingen
[3] Urologische Klinik, Georg-August-Universität, 37075 Göttingen
来源
Der Urologe | 2006年 / 45卷 / 2期
关键词
Androgen-independence; Androgen-receptor; Phytooestrogenes; Prostate cancer;
D O I
10.1007/s00120-005-0932-3
中图分类号
学科分类号
摘要
Introduction. Phytoestrogenes are plant-derived compounds that have been shown to exert an antiproliferative potential on prostate cancer cells, although the exact mechanisms are still unclear. In prostate cancer cells proliferation is regulated by modulation of the IGF-1 receptor (IGF-R-1) by the androgen receptor (AR) and its coactivator prostate derived Ets factor (PDEF). Phytooestrogenes interact with these mechanisms as demonstrated exemplarily in the presented study with the isoflavone tectorigenin derived from Belamcanda chinensis. Material and methods. Cultured androgen-sensitive LNCaP prostate cancer cells were treated with tectorigenin of 100 μM for 24 hours. The mRNA-expression of AR, PSA, PDEF, hTERT, TIMP-3 and IGF-R-1 were quantified by real-time RT-PCR. Furthermore, the expression or activity of PSA, telomerase and IGF-R-1 was measured on the protein level. In addition, we investigated in nude mice the influence of a diet of extracts of Belamcanda chinensis on the growth of subcutaneously injected LNCaP cells versus a control group of animals fed with a soy-free diet. Results. In cultured LNCaP cells treatment with tectorigenin resulted in a significant down-regulation of the gene expression of AR, PDEF, PSA, IGF-R-1 and hTERT. On the protein level PSA secretion and the activity of telomerase and IGF-R-1 expression was also decreased.The gene expression of TIMP-3 was distinctly up-regulated by tectorigenin. Nude mice fed with Belamcanda chinensis extract showed a significantly decreased incidence and tumor growth compared to controls. Conclusions. Tectorigenin shows an inhibition of the IGF-1-R modulated cell proliferation of PCa-Cells, due to modulation of the activity the co-activator PDEF independently from the AR. Furthermore, tectorigenin has pro-apoptotic effects and decreases tissue invasion by up-regulation of TIMP-3. Therefore, phytooestrogenes are an interesting option in the therapy of prostate especially advanced prostate cancer. © Springer Medizin Verlag 2005.
引用
收藏
页码:195 / 201
页数:6
相关论文
共 50 条
  • [1] Pharmacological potential of phytoestrogens in the treatment of prostate cancer
    Thelen, P
    Seseke, F
    Ringert, RH
    Wuttke, W
    Seidlová-Wuttke, D
    UROLOGE, 2006, 45 (02): : 195 - 201
  • [2] Androgen deprivation for advanced prostate cancer [Androgendeprivation in der therapie des prostatakarzinoms]
    Heidenreich A.
    Pfister D.
    Ohlmann C.H.
    Engelmann U.H.
    Der Urologe, 2008, 47 (3): : 270 - 283
  • [3] Potential of PET/MRI for diagnosis of prostate cancer [Potenziale der PET/MRT in der Diagnostik des Prostatakarzinoms]
    Röthke M.C.
    Afshar-Oromieh A.
    Schlemmer H.-P.
    Der Radiologe, 2013, 53 (8): : 676 - 681
  • [4] Irreversible electroporation: Current value for focal treatment of prostate cancer [Irreversible Elektroporation: Aktueller Stellenwert in der fokalen Therapie des Prostatakarzinoms]
    Wendler J.J.
    Ganzer R.
    Hadaschik B.
    Blana A.
    Henkel T.
    Köhrmann K.U.
    Machtens S.
    Roosen A.
    Salomon G.
    Sentker L.
    Witzsch U.
    Schlemmer H.P.
    Baumunk D.
    Köllermann J.
    Schostak M.
    Liehr U.B.
    Der Urologe, 2015, 54 (6): : 854 - 862
  • [5] EINFLUSS DES ZUSTANDES VON PLATINANODEN AUF DAS POTENTIAL DER SAUERSTOFFABSCHEIDUNG
    ERDEYGR.T
    VAJASDY, I
    ACTA CHIMICA ACADEMIAE SCIENTARIUM HUNGARICAE, 1961, 29 (01): : 47 - &
  • [6] Der Stellenwert von Bisphosphonaten in der Therapie des ProstatakarzinomsThe value of biphosphonates in the therapy of prostate cancer
    N. Rolfes
    G. Lümmen
    Der Urologe, 2009, 48 (9): : 990 - 996
  • [7] Diagnostics and treatment of prostate cancer after kidney transplantation [Diagnostik und therapie des prostatakarzinoms nach nierentransplantation]
    Wicht A.
    Hamza A.
    Loertzer H.
    Dietl M.
    Heynemann H.
    Fornara P.
    Der Urologe, 2006, 45 (1): : 32 - 37
  • [8] Antihormonelle Therapie des Prostatakarzinoms der 3. GenerationThird generation anti-androgen therapy of advanced prostate cancer
    C.-H. Ohlmann
    J. Kamradt
    M. Stöckle
    Der Urologe, 2012, 51 : 522 - 526
  • [9] Controversies in the therapy of high-risk prostate cancer: Radiotherapy [Kontroversen der Therapie des Hochrisiko-Prostatakarzinoms: Strahlentherapie]
    Böhmer D.
    Der Onkologe, 2015, 21 (9): : 805 - 814
  • [10] Arzneimittel im Gesamtkonzept der Therapie des ProstatakarzinomsIntegration of drug treatment in the management concept of prostate cancer
    R. Cathomas
    Der Internist, 2013, 54 : 1262 - 1270